Sarah C. Rutherford

Also affiliated with Weill Cornell Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma”.

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2405888

N/A

3.4DataRank · unranked

211 citations

Michael LeBlanc, Sharon M. Castellino, Hongli Li, Sarah C. Rutherford, Andrew M. Evens +42 more

Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma

Blood(2023)10.1182/blood.2022018254

N/A

1.3DataRank · unranked

46 citations

Alison J. Moskowitz, Neha Mehta–Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov +19 more

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Blood(2023)10.1182/blood.2023021274

N/A

0DataRank · unranked

47 citations

Nicholas Lambert, Paolo F. Caimi, Mwanasha H. Merrill, Priyanka Pullarkat, Richard Godby +19 more

NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826

Hematological Oncology(2023)10.1002/hon.3163_5

N/A

0DataRank · unranked

21 citations

Michael LeBlanc, Sharon M. Castellino, Huilin Li, Sarah C. Rutherford, Andrew M. Evens +41 more

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Blood Advances(2024)10.1182/bloodadvances.2023012090

N/A

0DataRank · unranked

2 citations

Jun Yin, Levi Pederson, Kristie A. Blum, Peter Martin, Sin‐Ho Jung +7 more

21 | PROGNOSTIC VALUE OF CIRCULATING TUMOR DNA IN PATIENTS WITH ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA TREATED ON SWOG S1826

Hematological Oncology(2025)10.1002/hon.70093_21

N/A

0DataRank · unranked

4 citations

Marcin Kaszkowiak, Michael LeBlanc, Chip Stewart, Alex F. Herrera, J Castillo +18 more

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Blood Advances(2025)10.1182/bloodadvances.2025018079

N/A

0DataRank · unranked

3 citations

Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand, John P. Leonard, Loretta J. Nastoupil +20 more

20 | IMPACT OF EBV STATUS AND HISTOLOGY ON OUTCOMES WITH NIVOLUMAB‐AVD VERSUS Bv‐AVD IN PATIENTS ENROLLED ON SWOG S1826

Hematological Oncology(2025)10.1002/hon.70093_20

N/A

0DataRank · unranked

1 citations

H. Li, Alex F. Herrera, Anamarija M. Perry, Alexandra E. Kovach, Kelly Davison +13 more

An intergroup collaboration for advanced stage classical Hodgkin lymphoma (cHL) in adolescents and young adults (AYA): SWOG S1826.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8067

N/A

0DataRank · unranked

8 citations

Michael LeBlanc, Alex F. Herrera, Susan K. Parsons, Angela Punnett, David Hodgson +8 more

127 | HEALTH‐RELATED QUALITY OF LIFE (HRQoL) ENDPOINTS OF THE PHASE III INTERGROUP S1826 ADVANCED‐STAGE, CLASSIC HODGKIN LYMPHOMA (cHL) TRIAL

Hematological Oncology(2025)10.1002/hon.70093_127

N/A

0DataRank · unranked

1 citations

H. Li, Alex F. Herrera, Kelly Davison, Sharon M. Castellino, Hildy Dillon +11 more

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8038

N/A

0DataRank · unranked

1 citations

Jun Yin, Levi Pederson, Betsy LaPlant, Mazyar Shadman, Hongli Li +15 more